Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Clinical trial NCT00400816 · COMPLETED

Trial details

NCT number: NCT00400816
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Tumors Brain Tumor

Start date: 2005-08-01
Primary completion: 2008-01-17
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.